Uzbekistan has received another 1 million doses of the Sino-Uzbek vaccine ZF-UZ-VAC 2001, the Ministry of Innovations said.
It is a novel recombinant coronavirus vaccine developed by scientists from the Institute of Microbiology of the Chinese Academy of Sciences and manufactured by the pharmaceutical company Anhui Zhifei Longcom Biopharmaceutical Co. Ltd. Its clinical trials were carried out in collaboration with Uzbek scientists.
The first batch of this vaccine was delivered to Uzbekistan on March 27 (1 million doses), the second batch – on April 27 this year (another 1 million doses).
It should be noted that scientists from the Center for Advanced Technologies under the Ministry of Innovative Development and the Research Institute of Virology under the Ministry of Health contributed to the large-scale research of the vaccine.
